Baidu
map

辟谣!南开大学回应“临床医学专业被撤销”

2021-03-07 南开大学 南开大学

针对媒体报道的“南开大学临床医学专业撤销”一事,南开大学3月2日晚间予以回应:这是对教育部文件的误读。南开大学临床医学专业并未撤销、停办,而是按照教育部要求,已由原来的七年制培

针对媒体报道的“南开大学临床医学专业撤销”一事,南开大学3月2日晚间予以回应:这是对教育部文件的误读。南开大学临床医学专业并未撤销、停办,而是按照教育部要求,已由原来的七年制培养改为“5+3”一体化专业培养模式。

南开大学方面指出,本次教育部列出的“撤销专业”指的是南开大学早已于2014年停止招生的临床医学七年制专业,并非现在的临床医学“5+3”一体化专业,也与临床医学其他专业无关。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1679601, encodeId=de8816e96013a, content=<a href='/topic/show?id=7c549386054' target=_blank style='color:#2F92EE;'>#辟谣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93860, encryptionId=7c549386054, topicName=辟谣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf127794231, createdName=feather87, createdTime=Sat Feb 05 19:35:51 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723304, encodeId=56c01e2330417, content=<a href='/topic/show?id=7375339953b' target=_blank style='color:#2F92EE;'>#医学专业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33995, encryptionId=7375339953b, topicName=医学专业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea333423126, createdName=xuruicheng, createdTime=Fri Mar 19 11:35:51 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035594, encodeId=956520355945a, content=<a href='/topic/show?id=741a3640618' target=_blank style='color:#2F92EE;'>#南开大学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36406, encryptionId=741a3640618, topicName=南开大学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Jan 07 04:35:51 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487889, encodeId=b786148e8896c, content=<a href='/topic/show?id=39cd5699947' target=_blank style='color:#2F92EE;'>#撤销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56999, encryptionId=39cd5699947, topicName=撤销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94e08379127, createdName=jiafufeng@yaho, createdTime=Mon Mar 08 16:35:51 CST 2021, time=2021-03-08, status=1, ipAttribution=)]
    2022-02-05 feather87
  2. [GetPortalCommentsPageByObjectIdResponse(id=1679601, encodeId=de8816e96013a, content=<a href='/topic/show?id=7c549386054' target=_blank style='color:#2F92EE;'>#辟谣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93860, encryptionId=7c549386054, topicName=辟谣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf127794231, createdName=feather87, createdTime=Sat Feb 05 19:35:51 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723304, encodeId=56c01e2330417, content=<a href='/topic/show?id=7375339953b' target=_blank style='color:#2F92EE;'>#医学专业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33995, encryptionId=7375339953b, topicName=医学专业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea333423126, createdName=xuruicheng, createdTime=Fri Mar 19 11:35:51 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035594, encodeId=956520355945a, content=<a href='/topic/show?id=741a3640618' target=_blank style='color:#2F92EE;'>#南开大学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36406, encryptionId=741a3640618, topicName=南开大学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Jan 07 04:35:51 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487889, encodeId=b786148e8896c, content=<a href='/topic/show?id=39cd5699947' target=_blank style='color:#2F92EE;'>#撤销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56999, encryptionId=39cd5699947, topicName=撤销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94e08379127, createdName=jiafufeng@yaho, createdTime=Mon Mar 08 16:35:51 CST 2021, time=2021-03-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1679601, encodeId=de8816e96013a, content=<a href='/topic/show?id=7c549386054' target=_blank style='color:#2F92EE;'>#辟谣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93860, encryptionId=7c549386054, topicName=辟谣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf127794231, createdName=feather87, createdTime=Sat Feb 05 19:35:51 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723304, encodeId=56c01e2330417, content=<a href='/topic/show?id=7375339953b' target=_blank style='color:#2F92EE;'>#医学专业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33995, encryptionId=7375339953b, topicName=医学专业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea333423126, createdName=xuruicheng, createdTime=Fri Mar 19 11:35:51 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035594, encodeId=956520355945a, content=<a href='/topic/show?id=741a3640618' target=_blank style='color:#2F92EE;'>#南开大学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36406, encryptionId=741a3640618, topicName=南开大学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Jan 07 04:35:51 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487889, encodeId=b786148e8896c, content=<a href='/topic/show?id=39cd5699947' target=_blank style='color:#2F92EE;'>#撤销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56999, encryptionId=39cd5699947, topicName=撤销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94e08379127, createdName=jiafufeng@yaho, createdTime=Mon Mar 08 16:35:51 CST 2021, time=2021-03-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1679601, encodeId=de8816e96013a, content=<a href='/topic/show?id=7c549386054' target=_blank style='color:#2F92EE;'>#辟谣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93860, encryptionId=7c549386054, topicName=辟谣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf127794231, createdName=feather87, createdTime=Sat Feb 05 19:35:51 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723304, encodeId=56c01e2330417, content=<a href='/topic/show?id=7375339953b' target=_blank style='color:#2F92EE;'>#医学专业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33995, encryptionId=7375339953b, topicName=医学专业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea333423126, createdName=xuruicheng, createdTime=Fri Mar 19 11:35:51 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035594, encodeId=956520355945a, content=<a href='/topic/show?id=741a3640618' target=_blank style='color:#2F92EE;'>#南开大学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36406, encryptionId=741a3640618, topicName=南开大学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Jan 07 04:35:51 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487889, encodeId=b786148e8896c, content=<a href='/topic/show?id=39cd5699947' target=_blank style='color:#2F92EE;'>#撤销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56999, encryptionId=39cd5699947, topicName=撤销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94e08379127, createdName=jiafufeng@yaho, createdTime=Mon Mar 08 16:35:51 CST 2021, time=2021-03-08, status=1, ipAttribution=)]

相关资讯

爱思唯尔宣布撤销 26 篇来自伊朗作者的论文

继今年早先施普林格大规模撤稿 107 篇稿件后,这次撤稿的是学术出版巨商爱思唯尔 (Elsevier)。12 月 21 日,爱思唯尔宣布准备撤稿旗下六个期刊接受发表的 26 篇论文,撤稿原因为同行评审造假和作者署名违规,这些论文在 2014 至 2017 年间发表,作者皆来自伊朗,其中有 24 篇的通讯作者都是同一个人:伊朗伊斯兰自由大学(Islamic Azad University)

美国韦恩州立大学教授因学术不端被撤销四篇论文

据Retraction Watch网站消息,因发现作者学术不端,《神经学》撤销了前美国韦恩州立大学Teresita L.Briones教授一篇论文。 该论文主要研究维生素D在大脑能量代谢中的作用。《神经学》发出通告称,美国科研诚信办公室调查发现,Teresita L.Briones在论文中伪造数据,随后《神经学》杂志主编要求撤销该稿件。 美国科研诚信办公室调查还发现,Teresita L.

美国MIT教授Robert Weinberg撤销一篇Cancer research论文

据Retraction Watch网站消息,由于数据出现问题,美国麻省理工学院Robert Weinberg教授撤销一篇Cancer research论文。 该论文主要研究癌症转移过程中的分子机制。《癌症研究》发出通告称,作者发现论文中部分数据是由不同批次实验拼凑而成,随后要求撤稿,并对此引起的不便表示歉意。 该论文的第一作者Scott Valastyan曾获得2011年的哈佛Runy

爱思唯尔因同行评审造假撤销中国9篇论文

据Retraction Watch网站消息,因论文同行评审造假,爱思唯尔出版商撤销旗下5本杂志中的9篇论文,这9篇论文全部来自中国高校或研究机构。 爱思唯尔发出声明称,出版伦理委员会调查发现这9篇论文的同行评审过程被人为操纵,随后爱思唯尔便撤销了这9篇论文。 自2012年来,爱思唯尔因同行评审造假而撤销的论文超过了20篇,所有出版商中因同行评审造假而被撤销的论文多达260篇。 爱思唯尔计

美国麻省理工学院教授撤销一篇《细胞》论文

据Retraction Watch网站消息,由于涉嫌学术不规范行为,麻省理工学院(Massachusetts Institute of Technology)Robert Weinberg教授撤销了一篇发表在《细胞》(Cell)上的研究论文。 该论文主要研究MicroRNA,用于抑制乳腺癌细胞扩散。Cell网站的通告称,作者发现论文部分数据是由不同批次实验拼凑而成,同时部分原始数据并不能

美国NIH研究人员因数据造假撤销一篇论文

据Retraction Watch网站消息,由于论文数据造假,美国NIH研究人员Arthur A. Hurwitz撤销了发表在《临床研究期刊》(Journal of Clinical Investigation)上的一篇研究论文。该论文主要研究人类和小鼠中前列腺癌的信号通路。《临床研究期刊》发布通告称, 经过NIH调查委员会广泛的调查,发现该论文的第一作者Stephanie Watkins博士伪造

Baidu
map
Baidu
map
Baidu
map